North Chicago Business
-
AbbVie donates $100 million to Puerto RicoMay 22, 2018 2:00 pm - AbbVie, a research-based global biopharmaceutical company, said it donated $100 million to two organizations, Direct Relief and Habitat for Humanity International, to st...
-
AbbVie ordered to pay $150 million damages in 'Low-T' trialJul 24, 2017 1:00 am - AbbVie was ordered to pay $150 million to an Oregon man who accused the drugmaker of hiding the heart-attack risks of its AndroGel testosterone booster, a loss for the N...
-
Abbott reports 3Q lossOct 19, 2016 7:00 am - NORTH CHICAGO, Ill. (AP) - Abbott Laboratories (ABT) on Wednesday reported a third-quarter loss of $329 million, after reporting a profit in the same period a year earli...
-
Job fair for military veterans Thursday in North ChicagoOct 12, 2016 1:00 am - The Lovell Federal Health Care Center will host a job fair from 10 a.m. to 2 p.m. Thursday, Oct. 13, in Bourke Hall, Building 4 on the campus at 3001 Green Bay Road, Nor...
-
Habitat for Humanity, Sysmex America dedicate North Chicago homeOct 02, 2016 11:00 pm - Submitted by The Message Group Recently, on a beautiful Saturday afternoon in North Chicago, the Anderson family was presented the key to their new Habitat for Humanity ...
-
AbbVie's lung cancer drug shows promise in first trialJun 07, 2016 1:00 am - NORTH CHICAGO - AbbVie Inc.'s experimental drug Rova-T showed promise in treating patients with an aggressive form of lung cancer in an early trial, a finding that may h...
-
AbbVie patent on Humira may be invalid, U.S. agency saysMay 17, 2016 1:00 am - One of AbbVie Inc.'s patents on its top-selling arthritis drug Humira may be invalid, a U.S. agency said, agreeing to consider a challenge filed by Coherus Biosciences I...
-
Abbott Labs to spend $25 billion to buy St. Jude MedicalApr 29, 2016 7:00 am - In a story April 28 about an Abbott Laboratories plan to buy St. Jude Medical, The Associated Press reported erroneously the deal's value. Abbott Laboratories will s...
-
Alere says it rejected Abbott's request to end acquisitionApr 29, 2016 1:00 am - Alere Inc. said it rejected Abbott Laboratories' request to terminate its $5.8 billion pending acquisition of the medical test maker, and that both companies are working...
-
AbbVie to acquire cancer drugmaker Stemcentrx for $5.8 billionApr 28, 2016 1:00 am - NORTH CHICAGO — AbbVie Inc. agreed to acquire cancer drugmaker Stemcentrx for $5.8 billion as it seeks to lower dependence on its top drug Humira. AbbVie will pay $2 bil...